MedTrace Logo

Growing Little PEAPODS Study

NCT06226051 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-08-12

No results posted yet for this study

Summary

The goal of this clinical trial is to learn more about how the food and nutrition babies receive while in the Neonatal Intensive Care Unit (NICU) influences their ability to gain weight and fat-free mass, and their future growth and development.

Participants will:

* have body growth measurements collected using the PEAPOD device
* have nutritional information collected, and
* be followed for neurodevelopmental outcomes

Participants can expect to be in the study for 36 months.

Conditions

  • Premature Birth
  • Premature Infant
  • Premature
  • Intrauterine Growth Restriction
  • Small for Gestational Age at Delivery

Interventions

DEVICE

PEAPOD Infant Body Composition measuring device

PEAPOD is a device to that collects body composition measurements.

Sponsors & Collaborators

  • Meriter Hospital, Inc.

    collaborator UNKNOWN

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Whitley Hulse, MD · University of Wisconsin, Madison

Eligibility

Min Age
22 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-04
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06226051 on ClinicalTrials.gov